Here are three quick facts.
1. Three investment analysts have given the stock a sell rating, five have given a hold rating and nine have given a buy rating.
2. Brokers have set a one-year consensus target price of $152.31 for the company.
3. Shares of athenahealth closed at $134.04 April 11.
More articles on finance and revenue cycle management:
Meet the online medical billing and coding training company that already has 1 million views on YouTube
5 most-read finance stories: Week of April 4-8
Intermedix names Jack Donahue head of EMS revenue cycle business
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.